Clinical Trial

Assessing Ovarian Function During Prolonged Implant Use

Study Description

Assessing Ovarian Function During Prolonged Implant Use

The study will evaluate how the ovaries may be functioning while using the the ImplanonAR/NexplanonAR during the three years beyond the FDA approved duration. Ovarian function will be assessed with weekly serum progesterone levels. Participants will undergo weekly venipuncture for a total of four draws. Participants will be followed for 30 days.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Device - Etonogestrel Implant

Ovarian function will be assessed with weekly serum progesterone levels. Participants will undergo weekly venipuncture for a total of four draws over a 30 day period. Participants will also complete a bleeding diary to assess daily bleeding patterns for the 30 day study period.

Additional Information

Official Study Title

Assessing Ovarian Function During Prolonged Implant Use

Clinical Trial ID

NCT03058978

ParticipAid ID

PdRJKd